Calculation of the Half-Life for the TL Signal of BeO Under Gamma and Alfa/Gamma Irradiation. [PDF]
Martinez-Baltezar R +4 more
europepmc +1 more source
Objective Systemic lupus erythematosus (SLE) significantly impacts employment capacity. This study aimed to investigate the impact of burden of disease activity, damage, and treatment on employment outcomes and transitions in patients with SLE. Methods Using data from a single center, we analyzed employment transitions, adjusted mean disease activity ...
Javier Mencia‐Ledo +4 more
wiley +1 more source
A Molecular Glue Approach to Control the Half-Life of CRISPR-Based Technologies. [PDF]
Sreekanth V +19 more
europepmc +1 more source
Facial Cosmetic Therapy Use Among Patients With Systemic Sclerosis: An Australian Cohort Study
Objective Systemic sclerosis (SSc) is associated with numerous facial manifestations for which patients may engage in cosmetic therapies. It is unclear how patients with SSc use these therapies. This study sought to characterize patient engagement and experiences with cosmetic therapies for SSc‐related and non‐SSc–related facial changes.
Zachary Warren +11 more
wiley +1 more source
Design and Synthesis of MBP-Fc-Bifunctional Peptide Inhibitor to Improve <i>In Vivo</i> Half-Life and Efficacy. [PDF]
Mahadik R +4 more
europepmc +1 more source
Biomedical research involving US veterans continues to advance health care beyond the Veterans Health Administration. This is particularly true in rheumatoid arthritis (RA), where veteran‐centric research has uncovered novel insights into pathogenesis, risk factors, and disease manifestations, informing clinical care and research across both veteran ...
Austin M. Wheeler +20 more
wiley +1 more source
Measuring the Elusive Half-Life of Samarium-146. [PDF]
Johnson-Groh M.
europepmc +1 more source
Real-World Use of Extended Half-Life Factor IX in Children with Haemophilia B. [PDF]
Dettoraki A +8 more
europepmc +1 more source
Glycoengineering of plant-produced Pembrolizumab enhances FcRn binding and extends serum half-life in mice. [PDF]
Bulaon CJI +9 more
europepmc +1 more source
Optimization of thrombopoietin mimetic peptide fusion proteins with albumin-binding domain for enhanced bioactivity and extended half-life. [PDF]
Ying J +5 more
europepmc +1 more source

